GlassScriptPhysician profile
Nathaniel L Bemis
NPI 1558642819
$1,616.52
in general payments reported to CMS, 2019-2025
12 companies · $70.68 in 2025
The $70.68 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2021: $36.71 · 2022: $460 · 2023: $686 · 2024: $261 · 2025: $70.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $530 · Travel and Lodging: $454 · Gift: $33.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $530.04 |
| Travel and Lodging | $454.26 |
| Gift | $33.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $487.96 | 2023 | |
| Patterson Companies, INC. | $452.35 | 2022-2025 | |
| Align Technology, INC. | $339.64 | 2019-2025 | Invisalign, Itero Element 5d Plus, Itero Element Flex |
| Dentsply Sirona INC | $119.15 | 2019-2024 | Midwest, Tph Spectra Universal Composite Restorative Low Viscosity |
| Biohorizons Implant Systems INC. | $52.72 | 2021-2024 | Biohorizons |
| Osteoready LLC | $50.00 | 2019 | |
| 3m Company | $28.04 | 2022 | |
| Biolase, INC. | $23.10 | 2022 | |
| Solventum Corporation | $18.00 | 2024 | 3m Scotchbond, 3m Filtek, 3m Relyx |
| Kerr Corporation | $15.27 | 2023 | Tf Adaptive |
| Nobel Biocare USA | $15.27 | 2023 | Nobelactive |
| Dmg America LLC | $15.02 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Bemis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.